Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
The Role of Opioids and Their Receptors in Urological Malignancy: A Review | Journal of Urology
Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Opioids to Treat Depression: The Jury Is Out
Opioids depress breathing through two small brainstem sites | eLife
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
Pathways and Receptors – Opioid Peptides
PDF) Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography
Antagonists of the kappa opioid receptor - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Distinct Mu, Delta, and Kappa Opioid Receptor Mechanisms Underlie Low Sociability and Depressive-Like Behaviors During Heroin Abstinence | Neuropsychopharmacology
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
κ-opioid receptor - Wikipedia
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction: Trends in Neurosciences
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect